It's swallowed as a capsule and affects the way your immune system works. Lenalidomide is a type of treatment known as a biological therapy. People with del(5q) can have severe anaemia (a lack of red blood cells), which requires regular blood transfusions. The medicine lenalidomide can be used to treat a rare type of MDS called deletion 5q, or del(5q). antibiotics to treat infections – if your white blood cell count is low.medicine to get rid of the excess iron in your blood – which can build up after a lot of blood transfusions.a blood transfusion – of either red blood cells or platelets, depending on which you need.injections of growth factor medicines, such as erythropoietin or G-CSF – to increase the number of healthy red or white blood cells.Symptoms of MDS can often be controlled with a combination of the following treatments: Treating your symptoms (supportive treatment) If your MDS has only a low risk of transforming into cancer, you may not need any treatment at first and may just be monitored with regular blood tests. The aim of treatment is to get the number and type of blood cells in your bloodstream back to normal and manage your symptoms. The type of treatment you get will depend on the type of MDS you have, your risk of developing AML, and whether you have any other health conditions. The risk of this happening depends on what kind of MDS you have, and the number of normal and abnormal blood cells you have.Īsk your doctor about your risk of developing AML. It can take a few months or up to several years before transformation takes place. Some people with MDS go on to develop acute myeloid leukaemia (AML), which is cancer of the white blood cells. They may find out they have MDS after having blood tests for something else. Some people with MDS don't have any symptoms. If you have any of these symptoms, you should speak to your GP about them. bruising and easy bleeding, such as nosebleeds (because of the low number of platelets).frequent infections (because of the low number of white blood cells).
0 Comments
Leave a Reply. |